Genetic Testing Company | The DNA Diagnostic Experts | GeneDx

In observance of the holidays, GeneDx will be closed for business on Thursday, December 25, 2014 and on Thursday, January 1, 2015. We will be unable to receive and process specimens. FedEx and UPS will also not be in operation. Except for the aforementioned dates, GeneDx will operate on our normal schedule (Monday-Saturday), including December 24th and December 31st.  If you have any questions or inquiries, please call us at 301-519-2100 or email us at zebras@genedx.com.

CNGA1 Gene Sequencing

FORMS AND DOCUMENTS

TEST DETAILS

Genes:
CNGA1
Disorders:
Clinical Utility:
  • Confirmation of a clinical diagnosis
  • To differentiate ARRP, adRP, and X-linked RP from other forms of retinal dystrophy and retinal degeneration
  • Recurrence risk assessment
  • Prenatal diagnosis
Lab Method:
Capillary Sequencing

ORDERING

Test Code:
417
Turnaround Time:
6-7 weeks
Preferred Specimen:
2-5 mL Blood - Lavender Top Tube

BILLING

CPT Codes:
81479x1
New York Approved:
No
ABN Required:
Yes
Billing Information:
View Billing Policy
ICD Codes:
  • 362.74: Pigmentary retinal dystrophy, Retinal dystrophy, albipunctate, Retinitis pigmentosa
  • 743.55: Congenital macular changes
  • 743.53: Chorioretinal degeneration, congenital
  • 743.54: Congenital folds and cysts of posterior segment
  • 362.76: Dystrophies primarily involving the retinal pigment epithelium, Fundus flavimaculatus, Vitelliform dystrophy
  • 362.75: Other dystrophies
  • 743.56: Other retinal changes, congenital
* For price inquiries please email zebras@genedx.com

REFERENCES

  1. Danciger M et al., (1996) Mol Vis 2:10
  2. den Hollander et al., (1999) Nat Genet 23:217–221
  3. den Hollander et al., (2001) Am J Hum Genet 69:198–203
  4. den Hollander et al., (2004) Hum Mutat 24:355-69
  5. Dreyer B et al., (2001) Am J Hum Genet 69:228-34
  6. Dreyer B et al., (2008) Hum Mutat 29:451
  7. Hanein S et al., (2004) Hum Mutat 23:306-17
  8. Huang SH et al., (1995) Nat Genet 11:468-71
  9. Lotery et al., (2001) Ophthalmic Genet 22:163-9
  10. McLaughlin ME et al., (1993) Nat Genet 4:130-4
  11. McLaughlin ME et al., (1995) Proc Natl Acad Sci 11;92:3249-53
  12. Morimura H et al., (1998) Proc Natl Acad Sci 95:3088–3093
  13. Pieke Dahl S et al., (1996 ) J Med Genet 33:753-7
  14. Rivolta C et al., (2000) Am J Hum Genet 66:1975–78
  15. Sandberg MA et al., (2008) Invest Ophthalmol Vis Sci 49:5532-9
  16. Seyedahmadi et al, (2004) Exp Eye Res 79:167-73
  17. Stone E (2007) Am J Ophthalmol 144:791-811
  18. Valverde D et al., (1996) Hum Mutat 8(4):393-4
  19. Weston et al., 2000 Am J Hum Genet 66:1199-210
  20. Wiszniewski W et al., (2005) Hum Mol Genet 1;14:2769-78
  21. Dryja et al., (1995) Proc. Natl Acad Sci 92:10177-10181
  22. Zhang et al., (2004) Mol Vis 10:884-889
  23. Paloma et al., (2002) J Med Genet 39:1-4
  24. Dryja TP et al., (1999) Invest Ophthalmol Vis Sci 40:1859-1865
  25. Danciger M et al., (1995) Genomics 1;30(1):1-7
  26. Collin RWJ (2009) ARVO meeting, May3-7, Fort Lauderdale, FL
  27. Collin RWJ et al., (2008) Am J Hum Genet 83:594-603
  28. Cremers FPM et al., (1998) Hum Molec Genet 7:355-362
  29. Booij JC (2005) J Med Genet 42:e67
  30. Bo Dreyer (2008) Hum Mutat 29:451
  31. Bernal S et al., (2003) J Med Genet 40:e89
  32. Bennett S et al., (2004) Pharmacogenomics 5:433-8
  33. Allikmets et al., (1998) Gene 215: 111- 122
  34. Abd El-Aziz MM et al., (2008) Nat Genet 40:1285-7
  35. Abd El-Aziz MM et al., (2007) Ann Hum Genet 71:281-94

Back To Top